Feb 18, 2021
Local research confirms the efficacy of Fermaid Ease
Feb 18, 2021
A scientific trial conducted at Charles Sturt University has confirmed the benefits of Fermaid Ease, a natural feed ingredient developed by Lallemand Animal Nutrition, in maintaining gastric comfort in intensively managed horses.
Gastric ulcers are a painful condition that can affect horse behaviour and performance. Nearly all horses develop gastric ulcers during training, with the incidence and severity worsening with increased work.
Intense exercise causes acidic stomach fluid to splash against the lining of the upper (squamous) region of the stomach, causing spot lesions or ulcers. While the lower (glandular) region of the stomach is naturally protected from inflammation, the squamous region is in a continual process of damage and repair.
A range of pharmaceutical drugs are available to prevent or treat gastric ulceration, but nonpharmaceutical methods are desirable.
Fermaid Ease is produced via the fermentation of soybean meal with a strain-specific lactic acid bacteria, Lactobacillus delbrueckii lactis Rosell 187. It helps maintain the integrity of the digestive tract by controlling gastric acid production and supporting cell regeneration.
Conducted by Professor Sharanne Raidal and Associate Professor Kris Hughes from CSU’s School of Animal and Veterinary Sciences, the trial investigated the impact of Fermaid Ease on gastric ulcer scores.
Gastroscopy of 120 horses presented to the CSU Veterinary Clinical Centre or at local training establishments identified 60 horses with spontaneous gastric ulcer disease. Of these, 29 horses were allocated to a treatment (25 g daily) or placebo group for 30 days.
Gastric scores were assessed at Day 31, at which time horses started the reciprocal treatment. Eleven horses successfully completed both treatment periods.
Horses treated with Fermaid Ease showed a significant decrease in squamous ulcer scores in both periods. No change was observed in squamous ulcer scores for horses receiving the placebo treatment in Period 1, with increased scores observed in Period 2. No effects were observed on glandular ulcer scores in either group or period.
The publication of the article is a pleasing outcome for Lallemand Managing Director, Alex Turney, who spent nine years locating the researchers and encouraging them to write a scientific paper.
For more information visit the Fermaid Ease product page.